Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
27.29
+0.30 (1.11%)
At close: Aug 13, 2025, 4:00 PM
26.99
-0.30 (-1.10%)
Pre-market: Aug 14, 2025, 8:55 AM EDT
Koninklijke Philips Market Cap
Koninklijke Philips has a market cap or net worth of $26.01 billion as of August 14, 2025. Its market cap has decreased by -1.54% in one year.
Market Cap
26.01B
Enterprise Value
33.78B
1-Year Change
-1.54%
Ranking
Category
Stock Price
$27.29
Market Cap Chart
Since December 1, 1998, Koninklijke Philips's market cap has increased from $15.62B to $26.01B, an increase of 66.56%. That is a compound annual growth rate of 1.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 25.24B | 9.99% |
Dec 31, 2024 | 22.95B | 11.60% |
Dec 29, 2023 | 20.56B | 57.66% |
Dec 30, 2022 | 13.04B | -60.89% |
Dec 31, 2021 | 33.35B | -30.89% |
Dec 31, 2020 | 48.26B | 8.19% |
Dec 31, 2019 | 44.61B | 37.19% |
Dec 31, 2018 | 32.52B | -7.46% |
Dec 29, 2017 | 35.14B | 23.45% |
Dec 30, 2016 | 28.46B | 19.64% |
Dec 31, 2015 | 23.79B | -12.24% |
Dec 31, 2014 | 27.11B | 42.97% |
Dec 30, 2011 | 18.96B | -31.76% |
Dec 31, 2010 | 27.79B | 4.28% |
Dec 31, 2009 | 26.65B | 48.16% |
Dec 31, 2008 | 17.98B | -53.52% |
Dec 31, 2007 | 38.69B | 13.76% |
Dec 29, 2006 | 34.01B | 20.84% |
Dec 30, 2005 | 28.15B | 17.36% |
Dec 31, 2004 | 23.99B | -8.90% |
Dec 31, 2003 | 26.33B | 64.54% |
Dec 31, 2002 | 16.00B | -39.26% |
Dec 31, 2001 | 26.35B | -19.70% |
Dec 29, 2000 | 32.81B | 7.41% |
Dec 31, 1999 | 30.55B | 83.48% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 592.95B |
Johnson & Johnson | 420.06B |
AbbVie | 355.91B |
UnitedHealth Group | 246.17B |
AstraZeneca | 240.81B |
Novartis AG | 234.72B |
Novo Nordisk | 227.37B |
Abbott Laboratories | 225.22B |